Bumrungrad International Hospital
| Thaïlande | Turquie | Espagne | |
| Thérapie par faisceau de protons | de $90,000 / 3,330,000฿ | de $70,000 / 2,590,000฿ | de $25,061 / 927,257฿ |
| Radiothérapie pour les sarcomes | de $7,000 / 259,000฿ | de $3,250 / 120,250฿ | de $8,000 / 296,000฿ |
| Radiothérapie pour le cancer colorectal | de $5,500 / 203,500฿ | de $7,000 / 259,000฿ | de $10,000 / 370,000฿ |
| Protonthérapie pour le cancer du sein | de $50,000 / 1,850,000฿ | de $30,000 / 1,110,000฿ | de $85,000 / 3,145,000฿ |
| Protonthérapie pour le cancer de la prostate | de $45,000 / 1,665,000฿ | de $30,000 / 1,110,000฿ | de $70,000 / 2,590,000฿ |
Bookimed ne rajoute pas de frais pour les traitements de Léiomyosarkome. Les tarifs proviennent des listes de prix officielles des cliniques. Vous payez directement à la clinique pour votre traitement à votre arrivée dans le pays.
Bookimed s'engage pour votre sécurité. Nous ne travaillons qu'avec des établissements médicaux qui respectent des normes internationales élevées dans le traitement de Léiomyosarkome et qui possèdent les licences nécessaires pour accueillir des patients internationaux dans le monde entier.
Bookimed offre une assistance experte gratuite. Un coordinateur médical personnel vous accompagne avant, pendant et après votre traitement, en résolvant tous les problèmes. Vous n'êtes jamais seul dans votre parcours de traitement de Léiomyosarkome.
Surgical resection is the primary treatment for localized leiomyosarcoma in Thailand. Thai oncology centers utilize a multidisciplinary approach combining surgery with chemotherapy and radiation. JCI-accredited facilities in Bangkok often employ precision medicine and en bloc resection to maximize survival rates.
Bookimed Expert Insight: Thai medical centers like Bumrungrad International Hospital manage over 1 million patients annually. Their high volume and JCI accreditation ensure specialized teams handle rare sarcomas regularly. Patients gain access to multidisciplinary tumor boards where surgeons and radiologists collaborate. This collective expertise is vital for complex cases like uterine or retroperitoneal leiomyosarcoma.
Patient Consensus: Patients emphasize that getting a second pathology opinion is crucial for rare tumors. They note that starting treatment at a large tertiary hospital in Bangkok helps avoid delays.
Bumrungrad International Hospital and Wattanosoth Cancer Hospital are premier Thai centers for soft-tissue sarcoma. These facilities utilize multidisciplinary teams for Leiomyosarcoma. They employ Joint Commission International standards and advanced technologies like CyberKnife. Precision radiation and specialized orthopedic oncology ensure comprehensive tumor management in Bangkok.
Bookimed Expert Insight: Bumrungrad International Hospital manages a massive volume of over 1 million patients annually. Their data shows that 50% of these patients travel from abroad. This high international ratio suggests their the Horizon Regional Cancer Center is exceptionally equipped for complex cross-border logistics. This experience helps ensure smoother coordination for foreign patients seeking specialized sarcoma care.
Patient Consensus: Patients find it essential to verify specific sarcoma programs before traveling to Thailand. They prioritize hospitals that provide a full team of oncologists and surgeons in one location.
Seek a sarcoma specialist for leiomyosarcoma (LMS). This rare cancer requires expertise in soft-tissue tumors. JCI-accredited hubs like Bumrungrad International Hospital in Bangkok offer necessary multidisciplinary teams. These teams include surgical oncologists and pathologists who specialize in rare sarcoma cases.
Bookimed Expert Insight: Thai medical hubs handle a massive volume of international cases yearly. Bumrungrad International Hospital treats over 1,000,000 patients annually from 190 countries. This high volume allows their 70 departments to maintain specialized sarcoma experience. Such concentration of rare cases typically results in more accurate tumor grading.
Patient Consensus: Patients emphasize that a standard oncologist is not enough for this rare cancer. They note that having specialists coordinate every step without delays prevents dangerous mismanagement.
Thailand offers advanced radiation for leiomyosarcoma through Volumetric Modulated Arc Therapy (VMAT) and CyberKnife radiosurgery. Specialized oncology centers in Bangkok use JCI-accredited protocols to treat soft-tissue sarcomas. These techniques protect healthy organs by delivering highly precise radiation doses to the tumor site.
Bookimed Expert Insight: While many search for specific machines, the highest-rated Thai hospitals differentiate through patient volume. Bumrungrad International Hospital alone serves 1,000,000 patients annually from over 190 countries. This massive throughput ensures their radiation oncology teams see more rare leiomyosarcoma cases than typical local centers. This experience is vital for planning radiation in sensitive areas like the retroperitoneum.
Patient Consensus: Patients emphasize that the skill of the sarcoma team matters more than the equipment. Many note that outcomes depend on whether the medical team treats rare soft-tissue sarcomas frequently.
Thailand oncology centers offer advanced leiomyosarcoma treatments beyond standard chemotherapy. Patients access newer combined regimens like trabectedin with doxorubicin. Precision medicine via next-generation sequencing identifies rare actionable mutations. JCI-accredited facilities in Bangkok provide targeted therapies and specialized radiation like CyberKnife and HIFU.
Bookimed Expert Insight: Bumrungrad International Hospital manages over 500,000 international patients yearly. Their scale allows them to maintain advanced diagnostic departments that many regional clinics lack. This high volume often means faster access to the molecular profiling needed for experimental drug eligibility. If standard chemotherapy fails, look for centers in Bangkok with dedicated sarcoma specialized oncology teams.
Patient Consensus: Patients emphasize getting tumor profiling done early to find rare targets. Many note that joining a trial is often the most realistic step when surgery is no longer an option.
Post-treatment monitoring for leiomyosarcoma focuses on intensive imaging and specialized clinical exams. Patients typically undergo CT or MRI scans every 3 to 4 months during the first 2 years. This rigorous schedule helps detect potential local recurrence or lung metastasis early when specialized treatments like CyberKnife are most effective.
Bookimed Expert Insight: Thai facilities like Bumrungrad International Hospital utilize AI and digital imaging to improve diagnostic accuracy. Data shows these centers manage over 1 million patients annually with a heavy focus on international oncology. Choosing a JCI-accredited facility ensures follow-up protocols meet global safety standards while providing access to specialized equipment like CyberKnife if recurrence is detected.
Patient Consensus: Patients emphasize that routine scans often catch recurrences before any physical symptoms appear. Many note that imaging is the primary tool for peace of mind because blood tests alone are insufficient for tracking this specific cancer.
During your consultation in Thailand, confirm the exact leiomyosarcoma stage and grade. Ask if a multidisciplinary tumor board will review your case. Demand a sarcoma-specialist pathology review and immunohistochemistry confirmation. Ensure the surgeon aims for wide negative margins to prevent recurrence.
Bookimed Expert Insight: Thailand's top facilities like Bumrungrad International Hospital serve over 190 countries and hold Global Healthcare Accreditation. Data shows these high-volume centers integrate digital imaging and AI for faster staging. A key advantage here is the speed of multidisciplinary coordination. You can often get pathology, MRI, and a tumor board review finished in 1 week.
Patient Consensus: Patients emphasize bringing your original biopsy slides and imaging disks to avoid diagnostic delays. They note it's vital to ask about a Plan B if the tumor is currently unresectable.